The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases

International Journal of Rheumatic Diseases

Volumn 13, Issue 3, 2010, Pages 259-265

  Ezzat, Yasser ^a   Hamdy, Khaled ^b  

^a FAYOUM UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Bone mineral density; Crohn's disease; Osteopenia; Osteoporosis; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; CALCIFEDIOL; CALCIUM; INFLIXIMAB; MESALAZINE; PHOSPHORUS; PREDNISOLONE; VITAMIN D;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; STEP WISE MULTIPLE REGRESSION; TREATMENT DURATION; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ALKALINE PHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BIOPSY; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; COLITIS, ULCERATIVE; COLONOSCOPY; CROHN DISEASE; EGYPT; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; LOGISTIC MODELS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PHOSPHORUS; RISK ASSESSMENT; RISK FACTORS; VITAMIN D; YOUNG ADULT;

EID: 77955396987     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01542.x     Document Type: Article

References (39)

1. Compston JE, Judd D, Crawley EO. Osteoporosis in patients with inflammatory bowel disease. Gut 1987, 28:410-5.
2. Pigot F, Roux C, Chaussade S. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992, 37:1396-403.
3. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med 2009, 122:599-606.
4. Jahnsen J, Falch JA, Aadland E, Mownickel P. Bone mineral density is reduced in patients with crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997, 40:313-9.
5. Gokhale R, Favus MJ, Karrison T. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998, 114:902-11.
6. Ghosh S, Gowen S, Hannan WJ, Ferguson A. Low bone mineral density in crohn's disease, but not in ulcerative colitis at diagnosis. Gastroenterology 1994, 107:1031-9.
7. Bjarnason I, Macpherson A, Mackintosh C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997, 40:228-33.
8. Lee SH, Kim HJ, Yang SK. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol 2000, 15:512-8.
9. Siffledeen JS, Siminoski K, Jen H, Fedorak RN. Vertebral fractures and role of low bone mineral density in crohn's disease. Clin Gastroenterol Hepatol 2007, 5:721-7.
10. Klaus J, Armbrect G, Steinkamp M. High prevalence of osteoporotic vertebral fractures in patients with crohn's diseaes. Gut 2002, 51:654-8.
11. Dear KL, Compston JE, Hunter JO. Treatment for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr 2001, 20:541-6.
12. Silvennoinen JA, Lehtola JK, Niemela SE. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996, 31:367-71.
13. Schulte C, Goebell H, Roher HD, Schulte KM. Genetic determinants of IL-6 expression levelsdo not infl uence bone loss in inflammatory bowel disease. Dig Dis Sci 2001, 46:2521-8.
14. Abitbol V, Roux C, Chaussade S. Metabolic bone assesment in patients with inflammatory bowel disease. Gastroenterology 1995, 108:417-22.
15. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone mineral density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995, 10:250-6.
16. Bischoff SC, Herrmann A, Goke M, Manns MP, Von zur Muhlen A, Barban G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997, 92:1157-63.
17. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998, 93:1483-90.
18. Redlich K, Hayer S, Ricci R. Osteoclasts are essential forTNF-alpha-mediated joint destruction. J Clin Invest 2002, 110:1419-27.
19. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med 2000, 133:795-9.
20. Manolagas SC. The role of IL-6 type cytokines and their receptors in bone. Ann NY Acad Sci 1998, 840:194-204.
21. Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 1998, 23:367-71.
22. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 24(Suppl 170):2-6.
23. Must A, Dallal GE, Dietz WH. Reference data for obesity (1991) 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 1991, 53:839-46.
24. Assessment of Fracture Risk and Its Application to Screening of Post-Menopausal Osteoporosis 1994, Technical report series 843, WHO, Geneva
25. Rodriguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease world. J Gastroenterol 2007, 13:6156-65.
26. Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S. Bone mineral content in patients withCrohn's disease. Alongitudinal study in patients with bowel resections. Scand J Gastroenterol 1997, 32:226-32.
27. Szathmari M, Pronai L, Tulassay Z. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1998, 93:848-9.
28. Pallone F, Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 1998, 43:735-41.
29. De Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH. Corticosteroids-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol 2002, 97:2011-5.
30. Noble CL, McCullough J, Ho W. Low body mass not vit D receptor polymorphism predict osteoporosis in patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2008, 27:588-96.
31. Leichtmann GA, Bengoa JM, Bolt MJG, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydroxy cholecalciferol in patients with both crohn's disease and intestinal resection. Am J Clin Nutr 1991, 54:548-53.
32. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D defiency and bone disease in patients with crohn's disease. Gastroenterology 1982, 83:1252-8.
33. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJM. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 2000, 119:1203-8.
34. Von Tirpitz C, Steder-Neukamm U, Glas K. Osteoporosis in infl ammatory bowel disease results of a survey among members of theGerman Crohn's and Ulcerative Colitis Association. Z Gastroenterol 2003, 41:1145-50.
35. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study ofbone mineral density in patients with inflamatory bowel disease. Gut 1995, 37:71-6.
36. Stockbrugger RW, Schoon EJ, Bollani S. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002, 16:1519-27.
37. Vestergaard P, Krogh K, Rejnmark L. Fracture risk is increased in crohn's disease but not in ulcerative colitis. Gut 2000, 46:176-81.
38. Recommendations for the prevention and treatment of glucocorticoid inducedosteoporosis. Arthritis Rheum 1996, 39:1791-801.
39. Van Staa TP, Leufkens HG, Abenhaim L. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000, 39:1383-9.